LCS
ZBH icon

Levin Capital Strategies’s Zimmer Biomet ZBH Stock Holding History

Levin Capital Strategies’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,432
Closed -$1.13M – 308
2018
Q2 		$1.13M Buy
+10,432
New +$1.14M 0.02% 134
2017
Q3 		– Sell
-220,887
Closed -$27.5M – 363
2017
Q2 		$27.5M Sell
220,887
-456,693
-67% -$54.1M 0.48% 38
2017
Q1 		$80.3M Buy
677,580
+104,863
+18% +$11.9M 1.43% 24
2016
Q4 		$57.4M Buy
572,717
+169,056
+42% +$18.1M 0.99% 31
2016
Q3 		$51K Sell
403,661
-254,034
-39% -$31.4M 0.75% 34
2016
Q2 		$76.9M Buy
657,695
+256,269
+64% +$29M 1.39% 22
2016
Q1 		$41.6M Sell
401,426
-297,458
-43% -$28.8M 0.75% 38
2015
Q4 		$69.6M Sell
698,884
-129,916
-16% -$12.7M 1.22% 23
2015
Q3 		$75.6M Buy
828,800
+134,464
+19% +$13.5M 1.29% 25
2015
Q2 		$73.6M Buy
694,336
+584,642
+533% +$64.7M 1.09% 30
2015
Q1 		$12.5M Buy
+109,694
New +$12.5M 0.19% 88

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Levin Capital Strategies's ZBH Position: Q3 2018 in Review

Levin Capital Strategies sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 10,432 shares — an estimated $1.13M sold.

Levin Capital Strategies first reported a position in ZBH in Q1 2015 and held it in 11 quarters. The position peaked at $80.3M in Q1 2017. 892 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

  • Levin Capital Strategies reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
  • Levin Capital Strategies sold 10,432 Zimmer Biomet shares in Q3 2018, an estimated $1.13M.
  • Levin Capital Strategies first reported a position in Zimmer Biomet in Q1 2015 and held it in 11 quarters.
  • Levin Capital Strategies's Zimmer Biomet position peaked at $80.3M in Q1 2017.
  • 892 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Levin Capital Strategies's 13F filing for Q3 2018, filed 29 Oct 2018.